Prevalence of uncontrolled severe persistent asthma in pneumology and allergy hospital units in Spain

Journal of Investigational Allergology and Clinical Immunology

Volumn 21, Issue 6, 2011, Pages 466-471

  Quirce, S ^a,b   Plaza, V ^b,c   Picado, C ^b,d   Vennera, M ^b,d   Casafont, Jordi ^e  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e Departamento Médico   (Spain)

Author keywords

Asthma; GINA guidelines; Prevalence; Uncontrolled

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E;

ADULT; ALLERGY; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRICK TEST; QUALITY OF LIFE; RISK FACTOR; SEVERE PERSISTENT ASTHMA; SKIN TEST; SPAIN;

EID: 80053948511     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA dissemination committee report. Allergy. 2004;59:469-78.
2. The International Study of Asthma and Allergies in Childhood (ISAAC Steering Committee). Worldwide variations in the prevalence of asthma symptoms; the International Study of Asthma and Allergies in Childhood (ISAAC). EurResp J. 1998;12:315-35.
3. European Community Respiratory Health Survey. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). EurRespir J. 1996;9:687-95.
4. García-Marcos L, Quirós AB, Hernández CG, Guillén-Grima F, Díaz CG, Ureña IC, Pena AA, Monge RB, Suárez-Varela MM, Varela AL, Cabanillas PG, Garrido JB. Stabilization of asthma prevalence among adolescents and increase among schoolchildren (ISAAC phases I and III) in Spain. Allergy. 2004;59:1301-7.
5. Martínez Moratalla J, Almar E, Sunyer J y el Grupo Español del Estudio Europeo del Asma. Identificación y tratamiento de individuos con criterios epidemiológicos de asma en adultos jóvenes de cinco áreas españolas. Arch Bronconeumol. 1999;35:223-8.
6. Sobradillo V, Miravitlles M, Jiménez CA, Gabriel R, Viejo JL, Masa JF, Fernández Fau L, Villasante C. Estudio IBERPOC en España: prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo. Arch Bronconeumol. 1999;35:159-66.
7. GINA Global Initiative for Asthma. Global strategy for asthma management and prevention NHBLI/WHO Workshop Report. 2007. Available from http://www.ginasthma.com.
8. Vermeire PA, Rabe KF, Soriano JB, Majer WC. Asthma control and differences in management practises across seven European countries. Resp Med. 2002;96:142-9.
9. Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, Weiss ST. Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. J Allergy Clin Immunol. 2007;119:1454-61.
10. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. EurResp J. 2000;16:802-7.
11. Fueyo A, Ruiz MA, Ancochea J, Guilera M, Badia X; ESCASE Group. Asthma control in Spain. Do season and treatment pattern matter? The ESCASE study. Respir Med. 2007;101:919-24.
12. Serra-Batlles J, Plaza V, Morejon E, Comella A, Brugues J. Costs of asthma according to the degree of severity. EurRespir J. 1998;12:1322-6.
13. Barnes PJ, Jonsson B, Klim JB. The costs of asthma. EurRespir. 1996;9:636-42.
14. Plaza V, Cobos A, Ignacio-García JM, Molina J, Bergonon S, García-Alonso F, Espinosa C. Coste-efectividad de una intervención basada en las recomendaciones de la Global Initiative for Asthma (GINA), mediante un sistema informatizado de apoyo a la decisión clínica: un ensayo con aleatorización de médicos. Med Clin. 2005;124:201-6.
15. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. EurResp J. 1999;14:902-7.
16. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992;47:76-83.
17. Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, Weiss ST. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol. 2004;114:40-7.
18. Finkelstein JA, Lozano P, Shulruff R, Inui TS, Soumerai SB, Ng M, Weiss KB. Self-reported physician practices for children with asthma: are national guidelines followed? Pediatrics. 2000;106:886-96.
19. López-Vina A, Cimas JE, Diaz Sanchez C, Coria G, Vegazo O, Picado Valles C. A comparison of primary care physicians and pneumologists in the management of asthma in Spain: ASES study. Res Med. 2003;97:872-81.
20. Fueyo A, Ruiz MA, Ancochea J, Guilera M, Badia X, ESCASE Group. Asthma control in Spain. Do season and treatment pattern matter? The ESCASE study. Respir Med. 2007;101:919-24.
21. de Miguel D, Barcina C, Muñoz M, Leal M. Control of persistent asthma in Spain: associated factors. J Asthma. 2008;45(9):740-6.
22. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113:59-65.
23. Osborne ML, Vollmer WM, Linton KL, Buist AS. Characteristics of patients with asthma within a large HMO. Am J RespirCrit Care Med. 1998;157:123-8.
24. Mosen DM, Shatz M, Magid DJ, Camargo CA. The relationship between obesity and asthma severity control in adults. J Allergy Clin Immunol. 2008;122:507-11.
25. Lavoie KL, Bacon SL, Labrecque M, Cartier A, Ditto B. Higher BMI is associated with worse asthma control and quality of life but not asthma severity Respir Med. 2006;100:648-57.